View drug registration information details.


ItemsRegistration information
ID87
No87
Brand NameMINOPHAGEN C
IngredientsMONOAMMONIUM GLYCYRRHIZINATE 53 MG (AS GLYCYRRHIZIC ACID 40 MG), GLYCINE JP 400 MG, L-CYSTEINE HYDROCHLORIDE HYDRATE 22.29 MG (L-CYSTEINE HYDROCHLORIDE 20 MG)
Dosage FormSOLUTION FOR INJECTION
Primary PackagingAMPOULES
StorageSTORE AT 1-25C
Shelf Life36 MONTHS
Pack Size20 ML/AMPOULES, BOX OF 30 AMPOULES
Dispensing CategoryPRESCRIPTION ONLY
ATC ClassificationA05BA08
Pharmaceutical ClassLIVER THERAPY
IndicationsECZEMA OR DERMATITIS, URTICARIA, PRURITUS, DRUG ERUPTION OR TOXICODERMA, STOMATITIS, INFANT STROPHULUS, PHLYCTEN. IMPROVEMENT OF ABNORMAL HEPATIC FUNCTION IN CHRONIC LIVER DISEASES.
ContraindicationsHISTORY OF HYPERSENSITIVITY, PATIENTS WITH ALDOSTERONISM, MYOPATHY AND HYPOKALAEMIA
Side EffectsRASH, UPPER ABDOMINAL DISCOMFORT
Unit Price
EDL No
DescriptionCOLORLESS, CLEAR AQUEOUS INJECTION IN GLASS AMPOULES
Note
License OwnerAI KEN PHARMA CO., LTD
ManufacturerMINOPHAGEN PHARMACEUTICAL CO.,LTD., ZAMA FACTORY
CountryJAPAN
Import Registration No21900AMX00144000
Import Registration Date2007-02-28
ActivityCERTIFICATE RELEASED
Applied Date2024-11-29
FDD Registration No02 I 5204/22
FDD Registration Date2024-12-16
Expiry Date2029-12-15

Back to drug list